Forty years of HIV research inspires the development of SARS-CoV-2 therapy
Dr. William Haseltine, Chair of ACCESS Health International and Dr. Roberto Partarca, Chief Medical Officer, were asked to contribute a journal article for the Journal of Molecular Cell Biology, on lessons from the HIV/AIDS pandemic for the treatment and prevention of COVID-19 …
Dr. William Haseltine receives the 2023 IHV Lifetime Achievement Award
ACCESS Health International Chair and CEO, Dr. William Haseltine recently received the 2023 Institute of Human Virology 25th Anniversary Lifetime Achievement Award for Scientific Contributions and Drug Development. Prior to founding ACCESS Health International. Dr. Haseltine helped create the biotechnology companies ProScript …
Recent Comments